Product Overview
Izempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used:
- along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.
- to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease.
Izempic® provides powerful A1C reductiona
The American Diabetes Association (ADA) recommends that a reasonable goal for most adults with type 2 diabetes is an A1C less than 7%.
A majority of adults taking Izempic® reached an A1C under 7% and maintained it.
How does Izempic cause weight loss?
GLP-1 agonists like Izempic help to control your blood glucose levels, but people taking them also tend to lose weight. GLP-1 is the key hormone involved in this process.
After you eat, cells in your intestines release GLP-1. This triggers insulin release and blocks glucose production. It also slows down how fast food leaves your stomach, making you feel full. GLP-1 is also thought to directly affect the appetite control area of your brain, as well as certain hunger hormones.
By mimicking the effects of GLP-1, Izempic can help curb your appetite and make you feel full so you consume fewer calories. This can result in weight loss.
How long does it take to lose weight on Izempic?
It can take a few months to reach your target dose of Ozempic. That’s because how much you inject is slowly increased over time to manage side effects. During this time, you may notice some weight loss. And how much weight you lose can depend on your Izempic dose.
The starting Ozempic dose for Type 2 diabetes is 0.25 mg once weekly for 4 weeks. This dose doesn’t typically have an effect on your blood glucose or weight. It’s meant to help your body get used to the medication. But after that, your dose is increased to 0.5 mg once a week.
During clinical trials, people taking the 0.5 mg dose lost around 8 lbs over 30 weeks. For some people, this dose isn’t enough for adequate blood glucose control. If needed, the dose may be increased in 4-week intervals up to a maximum of 2 mg once weekly.
In general, more weight loss and better blood glucose control are seen with higher Ozempic doses. During a 40-week study, people receiving the 1 mg Ozempic dose lost an average of 13 lbs. And people receiving the 2 mg Ozempic dose lost an average of 15 lbs.
Compared to Ozempic, Wegovy has a higher target dose — 2.4 mg once weekly. During the first 20 weeks (5 months) of treatment, people taking it during clinical trials lost 10% of their starting body weight. An additional 8% body weight loss was seen over the 48 weeks (about 11 months) that followed.